Johnson & Johnson Ireland
Cork: DePuy - Ringaskiddy; Janssen Biologics (Ireland) - Ringaskiddy; Janssen Pharmaceuticals - Little Island.
Limerick: VisionCare & IDC - Castletroy, Limerick; Ireland Development Centre (IDC) located onsite in the University of Limerick
Dublin: Janssen Alzheimer Immunotherapy - Grand Canal Street; Johnson and Johnson – Tallaght.
Johnson and Johnson is the world’s most comprehensive and broadly based manufacturer of healthcare products, as well as a provider of related services for the consumer, pharmaceutical and medical devices and diagnostics markets. Johnson and Johnson have more than 200 operating companies in 57 countries, selling products, throughout the world.
Johnson and Johnson was founded 125 years ago on a revolutionary idea: Doctors and nurses should use sterile sutures, dressings and bandages to treat peoples’ wounds. Since then every invention, every product, every breakthrough has been powered by generations of employees who are inspired to make a difference.
In Ireland Johnson and Johnson has been operating for more than 70 years across three business segments: Consumer, Medical Devices and Diagnostics and Pharmaceuticals.
Johnson & Johnson, VisionCare Ireland is located in Limerick and produces the Acuvue range of contact lenses which is the leading contact lens product in the world. Our Limerick site uses the most advanced technology in the industry and we now employ over 944 people directly. Using our highly automated production process, we produce daily disposable contact lenses while utilizing state of the art technologies such as injection molding, robotics, vision systems and sterilisation systems.
Johnson & Johnson, VisionCare Ireland was established in 1995 in the National Technology Park close to the University of Limerick. The facility was originally fitted with six advanced production lines to manufacture one daily disposable contact lens for the European and Japanese markets. Since then we have expanded a number of times and now have over 36 production lines manufacturing one-day, fortnightly, monthly and colour contact lenses which are shipped worldwide.
Each year, we have increased output because of the increase demand for our Acuvue lenses throughout the world. Continued expansion of our product lines and extensive engineering and retrofit projects ensure that this growth is sustained well into the future.
Janssen Biologics (Ireland)
Janssen Biologics established it’s operation in Ringaskiddy in 2005 on a 100 acre site with an investment of €500 million. For more than 25 years we have been a global leader in the field of biomedicines, in particular pioneering monoclonal antibody technology a cutting-edge approach to producing medicines that launched a new generation of products to treat immune related diseases such as rheumatoid arthritis and plaque psoriasis.
The facility in Ringaskiddy is now operational producing biomedicines for both the treatment of immune related diseases and new and innovative cancer treatments.
Janssen Pharmaceutical has been manufacturing bulk active pharmaceutical ingredients in Cork since 1981. Products are sold throughout the world to other Janssen and third party companies, where they are further processed into tablets, creams, or injectable dosage forms. These finished products are used in the treatment of a range of Psychiatric, Gastro Intestinal and Fungal disorders as well as in the treatment of HIV.
Janssen Alzheimer Immunotherapy
Established in 2009, Janssen Alzheimer Immunotherapy is based in Dublin and has a Research and Development facilities in South San Francisco. The company is involved in the research, development and commercialisation of selective products for the treatment and/or prevention of Alzheimer’s Disease. This includes bapineuzumab, a potential first-in-class treatment that is being
evaluated for slowing the progression of Alzheimer’s disease.
DePuy established its manufacturing facility in Cork in 1997 where is manufactures orthopedic knees and hips, from this date the company has expanded to include a Global Supply Chain Operation in 2002 and more recently in 2008 DePuy established an Innovation Centre which was created to develop next generation orthopedic products and processes for a global market.
DePuy are global leaders in providing healthcare solutions in orthopedics, spinal care, sports medicine and neurosciences.
Ireland Development Centre (IDC) located onsite in the University of Limerick - The newly formed Johnson & Johnson Ireland Development Centre (IDC) represents a new method & style of software delivery within the organization, a shift from the traditional waterfall approach. By adopting AGILE as the core approach, the IDC will transform the J&J Global delivery process, enabling high performing collaborative teams working across the entire enterprise.
Johnson & Johnson Dublin host the JNJ Commercial Teams. Johnson & Johnson Medical Companies produce a broad range of innovative products and solutions used primarily by health care professionals in the fields of orthopaedics, surgical oncology, general surgery, neurosurgery & neurological disease, infection prevention, cardiovascular disease, and aesthetics. As the most comprehensive devices business in the world, Johnson & Johnson Medical Devices is best suited to serve evolving customer needs, train more surgeons to improve standards of care, and treat more patients globally as access expands.
Please enter your email address
The purpose of this role is to ensure QC Microbiologyand in-process testing laboratories provide a compliant, timely and cost effective service during plant qualification phase and during routine plant operations.
Creating and developing customers is fundamental to our business and therefore, will be a prime responsibility. In addition, you will be expected to manage your territory as if it is your own business, maintaining key customers and core business whilst developing strategies to develop new business.
• Demonstrates a thorough understanding of the Irish healthcare, pharma and market access landscape alongside a working knowledge of global and EMEA HTA processes in order to develop, challenge, shape and implement local market access strategic plans.
The Director, Construction Management is responsible for the overall direction, coordination, implementation, execution, control and completion of capital project construction (ensuring consistency with Project Engineering Design, and project commitments and goals.
Injection Molding is a key core competency in our business and as such you will be looked to for technical leadership in the continuous effort to improve existing processes, develop new processes and improve equipment performance.